SCHEMBL9315751

SCHEMBL9315751

NCC(CC(=O)O)c1occ2cc(Br)ccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 5/20 0.41
GABBR1 Q9UBS5 5/20 0.41
LMNA P02545 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP3A4 P08684 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
NFKB1 P19838 1/20 0.38
DRD3 P35462 1/20 0.38
BLM P54132 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
MEN1 O00255 1/20 0.38
THRB P10828 1/20 0.38
TSHR P16473 1/20 0.38
KMT2A Q03164 1/20 0.38
PIM1 P11309 1/20 0.35
GAA P10253 1/20 0.34
ITGB3 P05106 1/20 0.34
ITGAV P06756 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9196657 0.84 GABBR2 (0.41) GABBR2GABBR1LMNACYP2C9CYP3A4
SCHEMBL9202387 0.84 GABBR2 (0.51) GABBR2GABBR1LMNACYP2C9CYP3A4
SCHEMBL9196668 0.84 MAPT (0.44) GABBR2GABBR1LMNACYP2C9CYP3A4
SCHEMBL9198986 0.82 GABBR2 (0.43) GABBR2GABBR1LMNACYP2C9CYP3A4
SCHEMBL9203501 0.82 GABBR2 (0.39) GABBR2GABBR1LMNACYP2C9CYP3A4
SCHEMBL9594090 0.81 PIM1 (0.39) GABBR2GABBR1LMNACYP2C9CYP3A4
SCHEMBL9200322 0.79 AKR1C3 (0.41) GABBR2GABBR1CYP2C9CYP1A2CYP2C19
SCHEMBL9195308 0.79 GAA (0.41) GABBR2GABBR1LMNACYP2C9CYP3A4
SCHEMBL10966532 0.77 TAAR1 (0.33) LMNACYP3A4ADORA3NFKB1BLM
SCHEMBL9315754 0.74 PIM1 (0.55) GABBR2GABBR1LMNAPIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5278166-A 4-amino-3-heteroaryl butyric acid compounds, compositions, and their use for treating disorders involving a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1994-01-11 US disclosed
US-5214063-A 4-aminobutyric acid compounds, compositions and methods of use for treating disorders related to a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1993-05-25 US disclosed
US-5162364-A Treatment of spastic and senescence disorders ADIR ET COMPAGNIE (FR) 1992-11-10 US disclosed